Barnwell Industries (BRN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Oct, 2026Executive summary
Board opposes Sherwood’s consent campaign, which seeks to replace the full Board and roll back certain bylaw amendments; it urges holders to return the WHITE consent revocation card.
Proposals require valid, unrevoked consents from holders of a majority of outstanding shares by May 13, 2025; the Board says its strategy includes winding down Hawaii operations and shifting most back-office work to Calgary.
Voting matters and shareholder proposals
Sherwood proposals seek to repeal bylaw amendments effective on or after Feb. 4, 2025, remove four incumbent directors, and elect five nominees through the 2026 annual meeting; the Board recommends against each.
As of the Mar. 14, 2025 record date, 10,053,534 shares were outstanding, with one vote per share; at least 5,026,768 unrevoked consents are required, due by May 13, 2025.
A signed WHITE card revokes prior consents where indicated; abstentions also revoke a prior consent, and holders may revoke before the proposals become effective.
Board of directors and corporate governance
The four incumbent directors are Kenneth S. Grossman, Joshua S. Horowitz, Alexander C. Kinzler and Douglas N. Woodrum; all but Kinzler are independent under NYSE American standards.
A Special Committee of Grossman and Horowitz was formed Nov. 7, 2024 to assess responses to the Sherwood contest and conduct settlement talks; an Executive Committee of Horowitz, Grossman and Kinzler followed on Feb. 18, 2025.
The Board says it offered to extend the 2023 cooperation agreement and proposed board compositions with Sherwood-backed representation, but those settlement efforts were rejected.
Latest events from Barnwell Industries
- Key votes center on expanding equity awards and ratifying grants above existing limits.BRN
Proxy filing - A disputed director slate, pending litigation and a rights plan frame the 2025 vote.BRN
Proxy filing - Proxy dispute delays the meeting; shareholders face four Board nominees and auditor ratification.BRN
Proxy filing - A 29.90% shareholder group presses for five board seats amid litigation and a consent drive.BRN
Proxy filing - A $50M shelf accompanies resale registration for 3.25M shares and warrant shares.BRN
Registration filing - A 29.90% shareholder group seeks a board overhaul and operational turnaround.BRN
Proxy filing - 2025 proxy fight centers on board control, strategy, and Sherwood's consent campaign.BRN
Proxy filing - Lower prices, production declines and impairment drove a wider Q1 loss as cash fell to $1.957M.BRN
Q1 2025 - Declining production and legal costs weigh on liquidity despite the $2.3M asset sale.BRN
Q3 2025